Latest News
Featured News
Preliminary Results for the Year Ended 30 April 2025
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Notice of Interim Results and Presentation
MHRA approval to add a third cohort using iSCIB1+ to the SCOPE trial
Result of 2023 Annual General Meeting
Update on SCOPE trial
Scancell presents positive data from the first stage in its Phase 2 SCOPE trial at the 20th International Congress of the Society for Melanoma Research
Scancell announces late-breaking abstract presenting positive data from the first stage in its Phase 2 SCOPE trial
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.